Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis

American Journal of Hypertension

Volumn 16, Issue 9 I, 2003, Pages 754-760

  Watanabe, Takuya ^a   Itokawa, Masashi ^a   Nakagawa, Yukiko ^a   Iguchi, Takashi ^a   Katagiri, Takashi ^b  

^a Showa University Karasuyama Hospital   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carotid atherosclerosis; Hypertension; Insulin like growth factor 1; Insulin like growth factor binding protein 3; Intimamedia thickness

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INTIMA; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0141506096     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00985-3     Document Type: Article

References (39)

1. Delafontaine P: Insulin-like growth factor 1 and its binding proteins in the cardiovascular system. Cardiovasc Res 1995;30:825-834.
2. Bayes-Genis A, Conover CA, Schwartz RS: The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 2000;86:125-130.
3. Frystyk J, Ledet T, Moller N: Cardiovascular disease and insulin-like growth factor I. Circulation 2002;106:893-895.
4. Ruotolo G, Bavenholm P, Brismar K, Efendic S, Ericsson CG, de Faire U, Nilsson J, Hamsten A: Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J Am Coll Cardiol 2000;35:647-654.
5. Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, Santeusanio F, Porcellati C, Brunetti P: Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999;100:1802-1807.
6. Anwar A, Delafontaine P: Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta. Hypertension 1994;24:679-685.
7. Grant MB, Wargovich TJ, Ellis EA, Tarnuzzer R, Caballero S, Estes K, Rossing M, Spoerri PE, Pepine C: Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens. Regul Pept 1996;67:137-144.
8. Okura Y, Brink M, Zahid AA, Anwar A, Delafontaine P: Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 2001;33:1777-1789.
9. Patel VA, Zhang QJ, Siddle K, Soos MA, Goddard M, Weissberg PL, Bennett MR: Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res 2001;88:895-902.
10. Anwar A, Zahid AA, Scheidegger KJ, Brink M, Delafontaine P: Tumor necrosis factor-α regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 2002;105:1220-1225.
11. Salonen JT, Salonen R: Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87(Suppl II):II56-II65.
12. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997;96:1432-1437.
13. Hollander M. Bots ML, Iglesias del Sol A, Koudstaal PJ, Witteman JCM, Grobbee DE, Hofman A, Breteler MMB: Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly. Circulation 2002;105:2872-2877.
14. Watanabe T, Koba S, Kawamura M, Itokawa, M, Idei T, Nakagawa Y, Iguchi T, Katagiri T: Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism 2004 (in press).
15. Jehle PM, Jehle DR, Mohan S, Bohm BO: Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients. J Endocrinol 1998;159:297-306.
16. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ: Localization of insulin-like growth factor 1 and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: a potential treatment for restenosis. Circulation 1994;89:1511-1517.
17. Polanco JI, Berciano MT. Lafarga M, Leon J, Pocovi M, Rodriguez-Rey JC: Expression of insulin-like growth factor receptor mRNA in rabbit atherosclerotic lesions. Biochem Biophys Res Commun 1995;209:182-190.
18. Wilson VJ, Ward JPT, Burnand KG, Thomas CR: Upregulation of IGF-I and collagen I mRNA in human atherosclerotic tissue is not accompanied by changes in type 1 IGF receptor or collagen III mRNA: an in situ hybridization study. Coronary Artery Dis 1996;7:569-572.
19. Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M, Caponnetto S, Cordera R: Insulin-like growth factor-1 and angiographically documented coronary artery disease. Am J Cardiol 1996;77:200-202.
20. Schuler-Luttmann S, Monnig G, Enbergs A, Schulte H, Breithardt G, Assmann G, Kerber S, von Eckardstein A: Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:1-6.
21. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T: Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002;106:939-944.
22. Motomura N, Lou H. Orskov H, Ramwell PW, Foegh ML: Exposure of vascular allografts to insulin-like growth factor-1 (IGF-I) increases vascular expression of IGF-I ligand and receptor protein and accelerates arteriosclerosis in rats. Transplantation 1998;65:1024-1030.
23. Touyz RM, Schiffrin EL: Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathway, Hypertension 1997;30:1440-1447.
24. Dominguez LJ, Barbagallo M, Sowers JR, Resnick LM: Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects. J Clin Endocrinol Metab 1998;83:4402-4407.
25. Delafontaine P, Lou H, Alexander RW: Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension 1991;18:742-747.
26. 1 integrin by means of its arg-gly-asp sequence. Proc Natl Acad Sci USA 1993;90:10553-10557.
27. Gonzalez B. Lamas S, Melian EM: Cooperation between low density lipoproteins and IGF-I in the promotion of mitogenesis in vascular smooth muscle cells. Endocrinology 2001;142:4852-4860.
28. Ko Y, Stiebler H, Nickenig G, Wieczorek AJ, Vetter H, Sachinidis A: Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-β on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Am J Hypertens 1993;6:496-499.
29. Scheidegger KJ, James RW, Delafontaine P: Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-I) receptor expression in vascular smooth muscle cells. J Biol Chem 2000;275:26864-26869.
30. Delafontaine P, Lou H: Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J Biol Chem 1993;268:16866-16870.
31. Delafontaine P, Anwar A, Lou H, Ku L: G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest 1996;97:139-145.
32. Grant MB, Wargovich TJ, Ellis EA. Caballero S, Mansour M, Pepine CJ: Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: a potential treatment for restenosis? Circulation 1994;89:1511-1517.
33. Emanuelsson H, Beatt KJ, Bagger J-P, Balcon R, Heikkila J, Piessens J, Schaeffer M, Suryapranata H, Foegh M: Long-term effects of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis. Circulation 1995;91:1689-1696,
34. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S. Orskov H: Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999;15:314-322.
35. Ceda GP, Dall'Aglio E, Magnacavallo A, Vargas N, Fontana V, Maggio M, Valenti G, Lee PDK, Hintz RL, Hoffman AR: The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab 1998;83:499-502.
36. Rifici VA, Schneider SH, Khachadurian AK: Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis 1994;107:99-108.
37. Martinez-Gonzalez J, Vinals M, Vidal F, Llorente-Cortes V, Badimon L: Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells. Atherosclerosis 1997;135:213-223.
38. Lemne C, Jogestrand T, de Faire U: Carotid intima-media thickness and plaque in borderline hypertension. Stroke 1995;26:34-39.
39. Van den Beld AW, Bots ML, Janssen JAMLL, Pols HAP, Lamberts SWJ, Grobbee DE: Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003;157:25-32.